Evidence map›Paper›PMID 32874130›Full record

ArticleCancer cell international2020

MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer epithelial cells via the

Kai Zhou, Binbin Song, Ming Wei, Jubo Fang, Yufen Xu

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. The Impact ofBiomedicines · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. miR-145-5p Inhibits HER2-Positive Breast Cancer Cells via Targeting ARF6.International journal of general medicine · 2025
    Article
  9. Glaucoma-Protective Human Single-Nucleotide Polymorphism in theArteriosclerosis, thrombosis, and vascular biology · 2024
    Article
  10. World journal of gastrointestinal oncology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Iranian journal of biotechnology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kai Zhou *Department of General Surgery, The Dongda Hospital, Shanxian, Heze, 274000 China.
Binbin Song *Department of Oncology, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, 1882# Zhonghuan South Road, Jiaxing, 314000 China.
Ming WeiDepartment of General Surgery, The Dongda Hospital, Shanxian, Heze, 274000 China.
Jubo FangDepartment of General Surgery, The Dongda Hospital, Shanxian, Heze, 274000 China.
Yufen XuDepartment of Oncology, The First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, 1882# Zhonghuan South Road, Jiaxing, 314000 China.
Xian Central Hospital · CNJiaxing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to investigate the relationship among miR-145-5p,

methodsqRT-PCR was carried out to detect the expression of miR-145-5p and

resultsThe expression of miR-145-5p was significantly down-regulated in GC cells, while that of

conclusionsMiR-145-5p plays an important role in GC epithelial cells, and it can affect cell proliferation, migration and invasion of GC cells by targeting

Indexed as

ANGPT2Gastric cancerMigration and invasionmiR-145-5pNOD_LIKE_RECEPTORProliferation

Identifiers

PMID32874130
PMCPMC7456024
OpenAlexW3081748491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.